Navigation Links
Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
Date:12/17/2007

s on capital availability, the potential dilutive effects of any financing, risks associated with the outcomes of our preclinical and clinical research and development programs, the adequacy, timing, and results of our clinical trials, competition, market acceptance of our products, the availability of government and insurance reimbursements for our products, the strength of intellectual property, reliance on partners, subcontractors, and key personnel, losses due to fluctuations in the U.S.-Canadian exchange rate, and other risks detailed from time to time in our public disclosure documents or other filings with the Canadian and U.S. securities commissions or other securities regulatory bodies. Additional risks and uncertainties relating to our Company and our business can be found in the "Risk Factors" section of our Annual Information Form and Form 20-F for the year ended November 30, 2006, as well as in our later public filings. The forward-looking statements are made as of the date hereof, and we disclaim any intention and have no obligation or responsibility, except as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Vasogen Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
7. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
8. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
9. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... protein functions in a wide variety of ways, including ... protein can take on another form and perform no ... fold wrongly can cause serious diseases such as Alzheimer,s, ... have a tendency to "infect" other molecules of the ... or plaques. These amyloids can damage cells and tissues ...
(Date:9/12/2014)... Switching the polarity of a magnet using an ... a working principle of the next-generation technology for ... candidates for the MEM effect, due to the ... other hand, the coexistence of spontaneous electric and ... hinders the application potential of the MEM effect. ...
(Date:9/12/2014)... 2014 Research and Markets has ... Photoresist Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... industry . The report provides a basic ... industry chain structure. The dry film photoresist market analysis ...
(Date:9/12/2014)... NM (PRWEB) September 12, 2014 Sandia ... an exclusive option agreement with STC.UNM (STC) for a ... Mexico (UNM) in Albuquerque, New Mexico, and Queen Mary ... of technologies, called the Recombinant Fluorescent Antibody Technology Platform ... Department of Internal Medicine and Dr. Angray Kang from ...
Breaking Biology Technology:Measuring modified protein structures 2Measuring modified protein structures 3Global Dry Film Photoresist Industry Report 2014 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 3Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 4
... the casual observer, responders contained the recent E. coli ... health professionals, the automated system used to identify the ... improvement. , ,Still, information technology played a key role ... and it will play an even greater role in ...
... about your firm? Slow? Fast? Lightning Speed? Not sure? , ... yet to adopt a wiki. A wiki, you ask, what's that? ... Today, it has come to mean a collaborative and group editable ... 2.0 that encourage conversations and draw on the power of social ...
... of change sparked by the information technology industry gives ... business challenge, but has IT really come through for ... recent Wisconsin technology conference, the results are mixed but ... Systems , brought together more than 300 corporate clients ...
Cached Biology Technology:Technology played key role in E. coli alerts 2Technology played key role in E. coli alerts 3Technology played key role in E. coli alerts 4Joining the wiki wacki world 2Joining the wiki wacki world 3Joining the wiki wacki world 4Joining the wiki wacki world 5Are businesses getting what they need from IT? 2Are businesses getting what they need from IT? 3
(Date:9/15/2014)... This news release is available in German . ... of a cell is straightforward: it doubles, divides in ... it has been long assumed that cells of the ... divide symmetrically. Silvia Bulgheresi,s team, University of Vienna, revealed ... long to be perceivable by the naked eye. These ...
(Date:9/15/2014)... in our cells cooperate with one another. But, it ... of different proteins find the correct dancing partners as ... and nervous system. A recent breakthrough at the University ... door and provided a look at the once obscure ... Jens Jrgen Led of the University of Copenhagen,s Department ...
(Date:9/15/2014)... tropical rainforest teeming with life it,s not what comes ... the first time evidence of Doncaster,s 310-million-year-old past, including a ... mining tip. , Some of the fossilised plants and creatures ... the egg case, several horseshoe crabs and some previously unrecorded ... preserved in rocks that formed within the coal and shale ...
Breaking Biology News(10 mins):Think big! Bacteria breach cell division size limit 2Protein courtship revealed through chemist's lens 2Protein courtship revealed through chemist's lens 3'Jaws' lived in Doncaster 2
... University researcher is studying whether the most popular ... in users. There is accumulating evidence that ... including muscle weakness, fatigue and deterioration ... radiology and osteopathic manipulative medicine at MSU. ...
... by a team of scientists using optical probes means ... now be seen in a completely different light. ... working with experts from Glasgow University, and a team ... the way that light was emitted by optical probes ...
... worldwide decline in the number of bees and other ... yields, according to the results of an international study ... journal, Current Biology . , Co-author, CSIRO ... detected warning signs that demand for pollinators is still ...
Cached Biology News:MSU researcher studies ties between cholesterol drugs, muscle problems 2Luminescence shines new light on proteins 2Pollinator decline not reducing crop yields just yet 2
Modified and insect cell culture tested....
BD BaculoGold Max-XP Insect Cell Medium 1 Liter...
Mycoplasma and virus tested...
Bethyl Laboratories Ready-To-Use IHC Bluing Reagent is used following IHC hematoxylin counterstaining with immunohistochemical procedures. Shelf-Life: 1 year from date of receipt...
Biology Products: